The overall objective of this project is to understand the molecular mechanism of MHV neuropathogenesis. The major goal of this project is to understand the molecular basis of viral tissue and cellular tropism. The progress made in the previous grant period has identified several cellular receptors for MHV infection. However, these receptors cannot totally account for viral tissue tropism. In this grant period, we propose to identify and study additional cellular receptors for MHV and the process of virus entry. Three specific projects will be performed: (1) Characterization of brain-specific MHV receptors. We have identified a carcinoembryonic antigen (CEA) which is expressed only in the brain, the only CEA molecule of this kind identified so far. We will determine its function as an MHV receptor, its neurobiology and role in the development of brain. Its biochemical properties and temporal and spatial expression patterns in the brain also will be examined. (2) Identification of additional brain-specific receptors for MHV in mice, rats and humans. Our data suggested that more than one CEA molecule can also serve as an MHV receptor. We want to examine whether CEA molecules in other species and other CEA molecules in mice can serve as MHV receptors. These studies will reveal the potential mechanism of MHV infections in mice as well as rats and primates. (3) Identification of cellular proteins interacting with MHV receptors and MHV structural proteins. Our studies have indicated the receptors alone are not sufficient to allow virus to enter cells. Other cellular factors are required. Preliminary data suggested that these cellular factors might interact directly or indirectly with receptors or with viral structural proteins. Therefore, we will use biochemical methods and molecular biology approaches to identify cellular proteins interacting with either CEA molecules or MHV structural proteins. The functions of these proteins in the viral entry process will be studied. These three projects will allow us to understand the molecular basis of viral tissue tropism.

Project Start
Project End
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
17
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Southern California
Department
Type
DUNS #
041544081
City
Los Angeles
State
CA
Country
United States
Zip Code
90089
Kapil, Parul; Butchi, Niranjan B; Stohlman, Stephen A et al. (2012) Oligodendroglia are limited in type I interferon induction and responsiveness in vivo. Glia 60:1555-66
Savarin, Carine; Stohlman, Stephen A; Rietsch, Anna M et al. (2011) MMP9 deficiency does not decrease blood-brain barrier disruption, but increases astrocyte MMP3 expression during viral encephalomyelitis. Glia 59:1770-81
Savarin, Carine; Stohlman, Stephen A; Atkinson, Roscoe et al. (2010) Monocytes regulate T cell migration through the glia limitans during acute viral encephalitis. J Virol 84:4878-88
Phares, Timothy W; Stohlman, Stephen A; Hinton, David R et al. (2010) Enhanced antiviral T cell function in the absence of B7-H1 is insufficient to prevent persistence but exacerbates axonal bystander damage during viral encephalomyelitis. J Immunol 185:5607-18
Phares, Timothy W; Ramakrishna, Chandran; Parra, Gabriel I et al. (2009) Target-dependent B7-H1 regulation contributes to clearance of central nervous system infection and dampens morbidity. J Immunol 182:5430-8
Zuo, Jun; Stohlman, Stephen A; Parra, Gabriel I et al. (2009) IL-15 independent maintenance of virus-specific CD8(+) T cells in the CNS during chronic infection. J Neuroimmunol 207:32-8
Savarin, Carine; Bergmann, Cornelia C (2008) Neuroimmunology of central nervous system viral infections: the cells, molecules and mechanisms involved. Curr Opin Pharmacol 8:472-9
Stohlman, S A; Hinton, D R (2001) Viral induced demyelination. Brain Pathol 11:92-106
Stohlman, S A; Bergmann, C; Cua, D et al. (1994) Location of antibody epitopes within the mouse hepatitis virus nucleocapsid protein. Virology 202:146-53
Strong, R K; Penny, D M; Feldman, R M et al. (1994) Engineering and expression of a secreted murine TCR with reduced N-linked glycosylation. J Immunol 153:4111-21